Dragon Pharma Primobolan 100 — Fresh Batch Tested by Janoshik.

[Anabolix]

Fresh Batch: Independent Janoshik Lab Testing of Dragon Pharma Primobolan 100 — What Does the Report Actually Show?​

Primobolan 100: What Does the Latest Independent Lab Report Tell Us About Batch MEHD4?​

When evaluating pharmaceutical or performance-enhancing products, product packaging and label claims are only one part of the picture. Independent laboratory analysis can provide additional information about what was detected in a particular sample and whether the reported concentration is consistent with the stated specification.

A recently provided Janosik Analytical test report for Dragon Pharma Primobolan 100 gives specific information about one production batch and is therefore worth examining from a quality and transparency perspective.

Fresh Laboratory Test Report​

The report identifies the following details:

• Product: Primobolan 100
• Active compound: Methenolone Enanthate
• Manufacturer: Dragon Pharma
• Batch: MEHD4
• Task Number: #218311
• Testing ordered: 05 August 2026
• Sample received: 20 August 2026
• Analysis conducted: 24 August 2026
• Test requested: Blind common anabolic steroid screening – oils
• Reported result: Methenolone Enanthate — 100.57 mg/ml

The reported result is particularly notable because the product is labeled at 100 mg/ml, while the laboratory report records 100.57 mg/ml in the tested sample.

Why Batch-Specific Testing Matters​

One of the most important points when discussing laboratory results is that a report applies to the sample that was actually analyzed. It should not automatically be assumed that an older report represents every subsequent production batch.

Batch-specific testing provides a more relevant reference because it connects the analytical result to an identifiable batch number. In this case, the report clearly identifies MEHD4, allowing the result to be discussed in the context of that particular batch rather than making a generalized claim about every Primobolan product.

The timing is also relevant. The report states that the sample was received on 20 August 2026 and the analysis was conducted on 24 August 2026, making this a recent test relative to the current batch discussion.

What Does the 100.57 mg/ml Result Mean?​

The laboratory report lists Methenolone Enanthate at 100.57 mg/ml.

From a purely analytical perspective, this result is close to the stated 100 mg/ml concentration on the product. The report also identifies Methenolone Enanthate as the compound detected during the requested screening.

However, laboratory concentration results should be interpreted carefully. A reported concentration does not automatically establish the overall quality, sterility, manufacturing conditions, or safety of an injectable product.

Laboratory Testing vs. Product Safety​

It is important to distinguish between analytical verification and medical safety.

A laboratory analysis can provide useful information about the tested sample, but it does not necessarily answer every question a consumer might have. For example, a particular analytical test should not automatically be interpreted as confirmation of sterility, absence of every possible contaminant, long-term stability, or suitability for an individual.

Likewise, a result from one tested sample cannot guarantee that every unit from a production run will have exactly the same characteristics.

Why the Fresh Report Adds Value​

The strongest aspect of this report is its specificity. Instead of simply stating that a product has been "lab tested," the document provides:

Product → Primobolan 100
Compound → Methenolone Enanthate
Batch → MEHD4
Laboratory task → #218311
Reported concentration → 100.57 mg/ml
Analysis date → 24 August 2026

That level of documentation makes the discussion more transparent because readers have concrete information to examine rather than relying exclusively on promotional statements.

Final Thoughts​

The fresh Janoshik Analytical report for Primobolan 100, batch MEHD4, reports 100.57 mg/ml of Methenolone Enanthate in the tested sample. The reported concentration is close to the product's stated 100 mg/ml specification, while the batch number and analysis date provide useful context for evaluating this particular test result.

For anyone researching the product, the most responsible approach is to consider the complete laboratory documentation, verify the report where possible, distinguish analytical findings from broader safety claims, and avoid treating a single laboratory result as a guarantee of product quality or personal safety.

Important: Methenolone and other anabolic-androgenic steroids can carry significant health risks and may be subject to prescription or other legal restrictions depending on the jurisdiction. This post discusses the supplied laboratory information and is not a recommendation to use anabolic steroids or a substitute for advice from a qualified healthcare professional.